Stocktitan

Published September 16, 2026

Optimi Health plans 2027 Phase 3 MDMA PTSD trial | OPTH SEC Filing - Stock Titan

Read the full story at Stocktitan

A planned Health Canada-authorized Phase 3 trial will study MDMA -assisted PTSD therapy in up to 100 veterans and frontline workers at Canadian.